2,4-Dichlorobenzofuro[3,2-d]pyrimidine, 97%, 500mg

2-Fluorothioanisole, 98.0%, 5g

2-[Ethyl(methyl)amino]acetohydrazide dihydrochloride, 95.0%, 10g

1,4-Bis(bromomethyl)-2-((2-ethylhexyl)oxy)-5-methoxybenzene, 98%, 5g

5-Chloromethyl-3-methyl-isoxazole-4-carboxylic acid ethyl ester, 95.0%, 1g

Benzofuran-3-carboxylic acid methyl ester, 95.0%, 250mg

Hidróxido de potasio, mínimo 85%, Ph.Eur., en gránulos, 1 kg, envase de plástico.

Methyl (R)-(+)-2,2-dimethyl-1,3-dioxolane-4-carboxylate, 95.0%, 25g

5'-(3-Carboxyphenyl)-[1,1':3',1''-terphenyl]-3,3''-dicarboxylic acid, 95%, 10g

Perfluoro-1,6-dibromo-2,5-dioxahexane, 98.0%, 5g

8-ethyl-4-(2-methoxybenzoyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Juego de diapositivas de contraste de fase con objetivos PLPHi IOS de 20x y S100x con corrección de infinito y anillos de contraste de fase para 20x/S100x

Perclorato de oxazina 720, mínimo 96 %, 500 mg, envase de vidrio